+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Idiopathic Inflammatory Myopathy (IIM) - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Idiopathic Inflammatory Myopathy (IIM) - Global Clinical Trials Review, 2026

  • Clinical Trials
  • August 2026
  • 311 Pages
  • Global
From
MMR Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

MMR Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 104 Pages
  • Global
From
Immunology Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region - Product Thumbnail Image

Immunology Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Aspergillosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type (Lentivirus), By Route Of Administration, By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type (Lentivirus), By Route Of Administration, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • July 2024
  • 120 Pages
  • Global
From
Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CRISPR Technologies: Intellectual Property Landscape(Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) - Product Thumbnail Image

CRISPR Technologies: Intellectual Property Landscape(Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

  • Report
  • August 2022
  • 121 Pages
  • Global
From
Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Thumbnail Image

Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Drug Pipelines
  • June 2025
  • 150 Pages
  • Global
From
Orphan Drugs Market 2024-2028 - Product Thumbnail Image

Orphan Drugs Market 2024-2028

  • Report
  • August 2024
  • 180 Pages
  • Global
From
11 Beta-Hydroxysteroid Dehydrogenase (11ßHSD) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

11 Beta-Hydroxysteroid Dehydrogenase (11ßHSD) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pompe Disease Drugs Market 2024-2028 - Product Thumbnail Image

Pompe Disease Drugs Market 2024-2028

  • Report
  • January 2024
  • 161 Pages
  • Global
From
Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 102 Pages
  • Global
From
Neuropathy Pain Treatment Market 2024-2028 - Product Thumbnail Image

Neuropathy Pain Treatment Market 2024-2028

  • Report
  • November 2023
  • 171 Pages
  • Global
From
Functional Dyspepsia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Functional Dyspepsia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Beta-1 Receptors Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-1 Receptors Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Epidermal Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Type-2 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Type-2 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Loading Indicator